ROS-mediated inactivation of the PI3K/AKT pathway is involved in the antigastric cancer effects of thioredoxin reductase-1 inhibitor chaetocinChuangyu Wen, Junsheng Peng|Cell Death and Disease|2019Cited by 129
The Advantages of Mesenchymal Stem Cell-Derived Extracellular Vesicles as Drug Delivery SystemsXiubin Kuang, Zhengqiang Yuan, Junsheng Peng et al.|Stem Cell Reviews and Reports|2025Cited by 3
Exosomal delivery of AZD5582 to overcome TRAIL resistance as an optimal therapy against triple-negative breast cancerWanting Zhang, Zhengqiang Yuan, Quanjiang Li et al.|Acta Histochemica|2025Cited by 2